Medicherla; Satyanarayana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Medicherla; Satyanarayana.The latest application filed is for "novel heterocyclic analogs of diphenylethylene compounds".

Company Profile

0.9.12

Medicherla; Satyanarayana - Cupertino CA
Medicherla; Satyanarayana - Sunnyvale CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic analogs of diphenylethylene compounds Grant 7,718,682 - Neogi , et al. May 18, 2	2010-05-18
Novel heterocyclic analogs of diphenylethylene compounds App 20080293949 - Neogi; Partha ; et al.	2008-11-27
Heterocyclic analogs of diphenylethylene compounds Grant 7,202,366 - Nag , et al. April 10, 2	2007-04-10
Novel heterocyclic analogs of diphenylethylene compounds App 20060235062 - Neogi; Partha ; et al.	2006-10-19
Heterocyclic analogs of diphenylethylene compounds Grant 7,105,552 - Nag , et al. September 12, 2	2006-09-12
Compounds to treat diabetes and associated conditions Grant 6,855,732 - Neogi , et al. February 15, 2	2005-02-15
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes Grant 6,852,695 - Nag , et al. February 8, 2	2005-02-08
Novel dipheylenthylene compounds App 20040259938 - Nag, Bishwagit ; et al.	2004-12-23
Treatment of obesity and associated conditions with TGF-beta inhibitors App 20040192583 - Medicherla, Satyanarayana ; et al.	2004-09-30
Novel heterocyclic analogs of diphenylethylene compounds App 20040186299 - Nag, Bishwajit ; et al.	2004-09-23
Methods for treating diabetes App 20040171659 - Medicherla, Satyanarayana ; et al.	2004-09-02
Novel heterocyclic analogs of diphenylethylene compounds App 20030181494 - Neogi, Partha ; et al.	2003-09-25
Diphenylethylene compounds Grant 6,624,197 - Nag , et al. September 23, 2	2003-09-23
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes App 20020193310 - Nag, Bishwajit ; et al.	2002-12-19
1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment Grant 6,448,450 - Nag , et al. September 10, 2	2002-09-10
Novel compounds to treat diabetes and associated conditions App 20020107285 - Neogi, Partha ; et al.	2002-08-08
Novel heterocyclic analogs of diphenylethylene compounds App 20020032225 - Nag, Bishwajit ; et al.	2002-03-14
Novel Heterocyclic analogs of diphenylethylene compounds App 20020025975 - Nag, Bishwajit ; et al.	2002-02-28
Novel diphenylethylene compounds App 20020002200 - Nag, Bishwagit ; et al.	2002-01-03
Heterocyclic analogs of diphenylethylene compounds Grant 6,331,633 - Neogi , et al. December 18, 2	2001-12-18
Diphenylethylene compounds Grant 6,245,814 - Nag , et al. June 12, 2	2001-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.